Stock search

Ticker or company name

West Pharmaceutical Services

WST · NYSE · Life Sciences Tools & Services

$417,80Up +1,38 (+0,33%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$28,7 bn
Div. yield
0,3%
Year to date
+51,3%
52 weeks: $223,83$438,27

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

7 ✓ · 1 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM45,543,737,9
Forward P/E40,5—29,5
PEG2,6—3,7
P/S8,67,76,6
EV/EBITDA30,029,629,9
P/FCF64,2—38,7
P/B9,88,85,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 21 analysts

Buy
20
Hold
1
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20262,212,66Up +20,2%
Q2 20262,102,37Up +12,8%
Q1 20261,692,13Up +25,8%
Q4 20251,852,04Up +10,2%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue875 m872 m845 m805 m805 m767 m698 m749 m747 m702 m695 m732 m
EPS3,022,151,921,821,921,821,231,781,851,511,551,83
Margin24,5%17,7%16,4%16,4%17,4%17,2%12,9%17,4%18,2%15,9%16,6%18,7%
FCF150 m80,8 m47,2 m175 m134 m102 m58,1 m85,2 m98,8 m64,8 m27,6 m130 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $6,57 m.

NameAmountSharesPrice
favorite annette f15 Sep 2026 · sale$921 2602 524$365,00
favorite annette f14 Sep 2026 · sale$887 5002 500$355,00
favorite annette f11 Sep 2026 · sale$862 5002 500$345,00
favorite annette f8 Sep 2026 · sale$852 0252 500$340,81
favorite annette f8 Sep 2026 · sale$960 4032 818$340,81
favorite annette f8 Sep 2026 · sale$960 0622 817$340,81
favorite annette f27 Apr 2026 · sale$859 7532 817$305,20
winters chad27 Apr 2026 · sale$269 399896$300,67

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NYSE
Country
US
IPO date
27 Jul 1923

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
ILMNIllumina, Inc.$198,0075would consider33,6+5,8%19,7%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
IQVIQVIA$264,7372would consider31,3+8,8%8,1%
WATWaters Corporation$453,4229would not consider269,0—1,8%
AAgilent Technologies$172,9278would consider34,1+8,6%19,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.